Abstract.
A LICORICE extract (glycyrrhizia), prepared from the root of the plant Glycyrrhizia glabra, has long been widely used for flavoring in food, beverages and medicines. The active compound in licorice is glycyrrhizin, a conjugate of 2 molecules of glucuronic acid and glycyrrhetic acid [1] [2] [3] . Glycyrrhizin is well known to be similar in its metabolic activities to mineralocorticoid [4, 5] . In addition, the development of pseudoaldosteronism, characterized by sodium retention, exaggerated potassium excretion, and suppression of both renin and aldosterone was described in patients who took large amounts of licorice or glycyrrhizin for long periods [1, [6] [7] [8] [9] . However, the alterations in blood pressure and electrolyte balance in patients taking licorice or glycyrrhizin were quantitatively variable, with some individuals showing little or no change, whereas others exhibited gross abnormalities [10, 11] . The present study demonstrated two points in patients with chronic hepatitis treated with 546mg of glycyrrhizin. First, 5 of the 12 patients showed an increase in blood pressure and a decrease in serum potassium (responders), while in the remaining 7 patients, these values remained stable (nonresponders). Second, the basal PRA values in the responders were different from those of the nonresponders. The patients with higher PRA were more likely to develop hypertension and hypokalemia.
Since Conn et al. [6] first described a case of pseudoaldosteronism caused by chronic, excessive licorice ingestion, similar cases have been reported in the literature [1, [7] [8] [9] . Glycyrrhizin and carbenoxolone, the semisynthetic hemisuccinate derivative of glycyrrhizinic acid, have been shown to have mineralocorticoid activity [3] [4] [5] .
In the present study, all patients taking glycyrrhizin showed a reduction in both PRA and PAC from the basal levels, indicating that glycyrrhizin acted as an exogenous mineralocorticoid and suppressed the renin-angiotensin-aldosterone systern. Although suppression of the reninangiotensin-aldosterone system was seen in all patients, an increase in blood pressure and a decrease in serum potassium were observed in 5 patients (responders). It has been shown that the development of hypertension and hypokalemia is not always observed in all patients taking glycyrrhizin or carbenoxolone. Indeed, Revers [16] reported the development of edema, shortness of breath and headaches in 20% of the patients treated with licorice; and Hausman et al. [11] described hypertension in 3 of 15 patients treated with carbenoxolone. While it is not entirely clear what dictates these differences in response, older people, perhaps due to a decreased binding of carbenoxolone to plasma albumin with a diminished plasma clearance rate [17] , and those with impaired renal or myocardial function are reported to be reliable indicators for predicting an increase in blood pressure or a decrease in serum potassium [18] . However, none of these factors could predict the development of hypertension and hypokalemia in our patients. Glycyrrhizin and carbenoxolone are almost entirely removed from the circulation by conjugation in the liver to form glucuronide, and reduced hepatic activity can clearly impair this mechanism [17] . As far as indocyanine green excretion, albumin, transaminases and prothrombin time were concerned, no differences were found between the responders and the nonresponders. Furthermore, since patients who progressed to liver cirrhosis were excluded from the study, we can rule out the possibility that the changes observed in the responders could be derived from the impaired metabolism of glycyrrhizin.
The only difference we found which clearly differentiated the responders from the nonresponders was the PRA value before the treatment, with patients having a PRA of more than 1.5 ng/ml/h being the responders and those having a PRA of less than 1.5 ng/ml/h being the nonresponders. The sympathetic nervous system is one of the major factors which determine the secretion of renin from the juxtaglomerular cells. Furthermore, the activation of the sympathetic nervous system or infusion of catecholamines is known to stimulate renin release [19] . In the present study, however, PNE of the responders, was not different from that of the nonresponder.
Therefore, it seems unlikely that the high PRAN levels in the responders derived from activation of the sympathetic nervous system. Sodium balance is another important factor affecting renin secretion. Low sodium intake is associated with increased secretion of renin through activation of the vascular stretch receptor and macula densa receptor [19] . It has been shown that mineralocorticoid cannot induce hypertension or hypokalemia when animals are placed on a low sodium intake [20] , and, furthermore, development of hypertension or hypokalemia induced by mineralocorticoid is shown to be sodium-dependent [21] . Therefore, although we did not examine sodium balance, these results suggest that the higher PRA levels observed in the responders were not due to a low dietary sodium intake. Furthermore, in the present study, PRA, PAC, MBP and potassium concentrations in the responders returned to basal levels after discontinuation of glycyrrhizin. PRA levels in the responders were still higher than 1.5 ng/ml/h. These results suggest that differences in the PRA in the responders and nonresponders were not due to differences in sympathetic nervous activity, blood pressure and sodium intake.
Although the mechanism(s) responsible for the high PRA levels in the responders remain unclear from the present study, it is concluded that patients with higher PRA levels are more likely to develop hypertension and hypokalemia due to glycyrrhizin.
